Skip to content

Clinical trials

Pulmonary Fibrosis trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Fibrosis Country / region: South Korea Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20072
20111
20191
20202
20211
20222
20233
20241
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting4
Completed4
Terminated4
Not yet recruiting1
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb4
Boehringer Ingelheim2
Endeavor Biomedicines, Inc.2
Kyntra Bio2
Amgen1
Contineum Therapeutics1
Interstitial Lung Disease Study Group, Korea1
Pliant Therapeutics, Inc.1
PureTech1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Fibrosis15
Idiopathic Pulmonary Fibrosis11
Lung Diseases, Interstitial5
Idiopathic Interstitial Pneumonias3
Arthritis, Rheumatoid1
Connective Tissue Diseases1
Fibrosis1
Hypertension, Pulmonary1
Respiration Disorders1
Sarcoidosis1

Trials

Showing 51 to 15 of 15. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.